Taken all together and as shown in Figure 7, oral administration of IL-35-producing strain Pichia/IL-35 could ameliorate experimental colitis, which may involve upregulation of TCPTP expression in intestinal macrophages. This evidence concerns the gene PTPN2 and colitis.